Identification of cCMP binding and activated proteins

  • Stefanie Wolfertstetter
  • Elisabeth Schinner
  • Franz Hofmann
  • Jens Schlossmann
Open Access
Poster presentation


Protein Kinase Pyrimidine Purine Vascular Smooth Muscle Cyclic Nucleotide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


cAMP and cGMP are well established second messengers and essential for numerous of (patho)physiological processes. These purine cyclic nucleotides activate PKA and PKG, respectively. So far, there was no evidence of further cyclic nucleotides acting as second messengers. Meanwhile the existence of cCMP was described [1]. Formation of the cyclic pyrimidine nucleotide cyclic cytidine 3’,5’-monophosphate (cCMP) by cytidylyl cyclases is debated. cCMP induces relaxation of vascular smooth muscle via cGKI [2]. Furthermore, it was postulated that cCMP is relevant for cell growth [3] and blood cell function [4]. However, functions regulated by cCMP are mostly unknown.


Our aim is to identify cCMP-binding and -acitvated proteins and to elucidate whether cCMP plays a role as second messenger. We confirmed that cCMP activates the purified cyclic nucleotide-dependent protein kinases cAK and cGK. Then we investigated the effect of cCMP on purified cyclic nucleotide-dependent protein kinases and on intact tissues of wildtype (WT) and cGKI-knockout (KO) mice, namely jejunum, lung and brain. We identified various protein kinases as cCMP-binding proteins in tissue lysates. cCMP stimulated cyclic GMP-dependent protein kinases in WT tissue lysates, however there was no stimulation of phosphorylation in KO tissue lysates.


These results indicate that cCMP could play a role in physiological processes in jejunum, lung and brain.


  1. 1.
    Newton RP, Salih SG, Salvage BJ, Kingston EE: Extraction, purification and identification of cytidine 3',5'-cyclic monophosphate from rat tissues. Biochem J. 1984, 21: 665-673.CrossRefGoogle Scholar
  2. 2.
    Desch M, Schinner E, Kees F, Hofmann F, Seifert R, Schlossmann : Cyclic cytidine 3',5'-monophosphate (cCMP) signals via cGMP kinase I. FEBS Lett. 2010, 584: 3979-3984. 10.1016/j.febslet.2010.07.059.CrossRefPubMedGoogle Scholar
  3. 3.
    Cheng YC, Bloch A: Demonstration, in leukemia L-1210 cells, of a phosphodiesterase acting on 3':5'-cyclic CMP but not on 3':5'-cyclic AMP or 3':5'- cyclic GMP. J Biol Chem. 1978, 253: 2522-2524.PubMedGoogle Scholar
  4. 4.
    Ervens J, Seifert R: Differential modulation by N4, 2'-O-dibutyryl cytidine 3':5'-cyclic monophosphate of neutrophil activation. Biochem Biophys Res Commun. 1991, 74: 258-267.CrossRefGoogle Scholar

Copyright information

© Wolfertstetter et al; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Authors and Affiliations

  • Stefanie Wolfertstetter
    • 1
  • Elisabeth Schinner
    • 1
  • Franz Hofmann
    • 2
  • Jens Schlossmann
    • 1
  1. 1.Department of Pharmacology and ToxicologyUniversity of RegensburgGermany
  2. 2.FOR923, Institute for Pharmacology and Toxicology, TUMunichGermany

Personalised recommendations